Here we demonstrate that KLF4K409Q mutation in meningioma leads to an upregulated HIF-1α pathway, leaves cells susceptible to hypoxia and that this effect can be blocked by mTOR inhibition with Temsirolimus. Here, MTOR is linked to meningioma.